Refrigerate At 2-8°C Somatropin Injection Injectable Dosage Form Typically 24 Months Shelf Life Hormone Therapy Product

Product Description:

Somatropin Injection is a highly effective therapeutic product primarily used for hormone replacement therapy and growth hormone deficiency treatment. This medication is presented in an injection form, specifically designed for subcutaneous or intramuscular administration, ensuring efficient absorption and optimal results. Somatropin, commonly known as human growth hormone (HGH), plays a vital role in stimulating growth, cell reproduction, and regeneration in patients requiring hormone supplementation.

The product is typically supplied as an injection pen, which offers a convenient and precise method for self-administration. The injection pen design enhances ease of use, accuracy in dosing, and comfort during administration, making it an ideal choice for both pediatric and adult patients. The portability of the injection pen allows patients to maintain their treatment regimen with minimal disruption to their daily activities, providing a discreet and user-friendly solution for HGH therapy.

Somatropin Injection has a shelf life of typically 24 months when stored under recommended conditions. Proper storage is critical to maintaining the efficacy and safety of the hormone. It must be refrigerated at temperatures between 2 to 8 degrees Celsius and should never be frozen. These storage conditions help preserve the biological activity of the hormone and prevent degradation. Patients are advised to avoid exposing the injection pen to extreme temperatures or direct sunlight to ensure the product remains stable throughout its shelf life.

Common side effects associated with Somatropin Injection include injection site reactions, such as redness, swelling, or mild discomfort, which are generally transient and resolve without intervention. Other side effects may include headaches, edema (fluid retention causing swelling), and muscle pain. These adverse effects are typically manageable and often diminish as the body adjusts to the therapy. However, it is important for patients to report any persistent or severe symptoms to their healthcare provider to ensure appropriate management and to rule out any complications.

The administration route of Somatropin Injection is either subcutaneous or intramuscular, depending on the specific clinical requirements and physician’s recommendation. The subcutaneous route involves injecting the hormone into the fatty tissue just beneath the skin, which is commonly preferred due to ease of administration and patient comfort. Intramuscular injections deliver the hormone directly into muscle tissue, which may be chosen based on patient-specific factors or treatment protocols. The use of the injection pen facilitates both routes, providing versatility and adaptability in treatment administration.

Somatropin Injection, delivered via the injection pen, is an essential component in managing various growth hormone-related conditions. It supports normal physical growth and development in children with growth hormone deficiency and helps adults with similar deficiencies improve muscle mass, bone density, and overall metabolic functions. The convenience of the injection pen combined with the proven efficacy of HGH therapy makes Somatropin Injection a preferred choice among patients and healthcare professionals alike.

In summary, Somatropin Injection is a reliable, user-friendly HGH therapy solution available in a convenient injection pen format. With a typical shelf life of 24 months and strict storage conditions requiring refrigeration between 2-8°C without freezing, it ensures sustained potency and safety. While common side effects like injection site reactions, headache, edema, and muscle pain may occur, they are generally mild and manageable. The flexibility of administration routes—subcutaneous or intramuscular—allows personalized treatment approaches, enhancing patient adherence and therapeutic outcomes. Somatropin Injection pen stands out as a vital tool in hormone replacement therapy, empowering patients with a practical and effective method to manage growth hormone deficiency.

Features:

• Product Name: Somatropin Injection
• Contains human growth hormone (hgh) for effective treatment
• Available in various strengths (e.g., 5 Mg, 10 Mg per vial)
• Delivered via convenient injection pen for ease of use
• Contraindications include active malignancy, acute critical illness, and hypersensitivity to somatropin
• Storage conditions: Refrigerate at 2-8°C; do not freeze
• Prescription status: Prescription only medication
• Manufactured by various reputable manufacturers (e.g., Pfizer, Novo Nordisk)

Technical Parameters:

Applications:

The Somatropin Injection, branded as Delfu and model number BZ-18, is a highly specialized pharmaceutical product originating from China. This injection pen is designed for the administration of somatropin, a form of human growth hormone that plays a crucial role in stimulating growth and cell reproduction by mimicking the natural growth hormone produced by the body. The product is primarily used in medical scenarios where there is a deficiency or insufficiency of growth hormone, providing an effective therapeutic solution to promote normal growth and development.

Somatropin Injection finds its application in a variety of clinical occasions and scenarios. It is commonly prescribed for pediatric patients suffering from growth hormone deficiency, helping children achieve normal height and development milestones. Additionally, it is used in adults with growth hormone deficiency resulting from pituitary gland dysfunction, supporting improved body composition, increased muscle mass, and enhanced energy levels. The injection pen format ensures precise dosing and convenient administration, enabling patients to self-administer the hormone with ease and confidence.

Beyond growth hormone deficiency, the Delfu Somatropin Injection pen is utilized in certain cases of chronic kidney disease in children, Turner syndrome, and Prader-Willi syndrome, where growth impairment is a significant concern. Its mechanism of action, which involves stimulating cellular growth and replication, makes it an indispensable tool in managing these complex conditions. The product must be stored under strict conditions, specifically refrigerated at 2-8°C and not frozen, to maintain its efficacy and safety.

The use of Somatropin Injection is contraindicated in patients with active malignancy, acute critical illness, or hypersensitivity to somatropin. These contraindications ensure that the treatment is administered safely and only to suitable candidates. Healthcare professionals must carefully evaluate patient history and current health status before initiating therapy with this human growth hormone injection pen.

In summary, the Delfu Somatropin Injection pen (BZ-18) is an essential therapeutic option for patients requiring growth hormone replacement or supplementation. Its precise delivery system, combined with the potent biological activity of somatropin, addresses a range of growth-related disorders effectively. Proper storage and adherence to contraindications further enhance the safety and effectiveness of this advanced injection pen from China.

Customization:

The Somatropin Injection by Delfu, model number BZ-18, is a high-quality human growth hormone product originating from China. This prescription-only injection is designed for administration via subcutaneous or intramuscular routes, ensuring effective delivery of the hormone. Available in a convenient 3ml cartridge, it can be used with an injection pen for precise and easy dosing. The dosage form is injection, and it requires proper storage conditions; refrigerate at 2-8°C and do not freeze to maintain its potency. The shelf life of this product is typically 24 months, guaranteeing long-lasting efficacy when stored correctly.

Support and Services:

For technical support and services related to Somatropin Injection, please refer to the product's detailed instructions and guidelines provided with your medication. Ensure that you follow the prescribed dosage and administration procedures as directed by your healthcare provider. If you experience any adverse reactions or require assistance with storage, handling, or administration, consult your pharmacist or healthcare professional promptly. Proper storage conditions must be maintained to preserve the efficacy of Somatropin Injection. Always use the product within the expiration date and do not share your medication with others. For further technical information or support, refer to the official product documentation and consult authorized medical personnel.